Collaxio (COLLAX) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
19 Aug, 2026Executive summary
Portfolio expanded to 21 holdings after completing the Aggregate Media acquisition, including NF11 Holding (NordicFeel) and Medicheck.
Net asset value (NAV) at June 30, 2026, was 100 MSEK, up from 89 MSEK at March 31, 2026.
Q2 2026 result improved to -1.7 MSEK from -15.2 MSEK in Q2 2025; H1 2026 result was -1.9 MSEK versus -22.4 MSEK in H1 2025.
No dividend for 2025; Peter Brodén appointed as new chairman.
Financial highlights
NAV per share at June 30, 2026: 1.16 SEK (down from 1.46 SEK at March 31, 2026).
Assets under management (AUM) at June 30, 2026: 110 MSEK (111 MSEK at March 31, 2026).
Q2 2026 result: -1.7 MSEK (Q2 2025: -15.2 MSEK); H1 2026 result: -1.9 MSEK (H1 2025: -22.4 MSEK).
Q2 2026 EPS: -0.02 SEK (Q2 2025: -0.52 SEK); H1 2026 EPS: -0.03 SEK (H1 2025: -0.77 SEK).
Management costs for Q2 2026: -2.2 MSEK (2.21% of NAV), down from -4.9 MSEK (5.61%) in Q2 2025.
Outlook and guidance
Focus remains on disciplined, selective investments and active ownership to drive value.
Positive outlook based on portfolio growth and market acquisition opportunities.
Latest events from Collaxio
- NAV at 89 MSEK, 19 holdings, 61% portfolio revenue growth, and improved cost efficiency.COLLAX
Q1 2026 - Strategic shift to unlisted assets and acquisitions drove transformation, but NAV per share fell.COLLAX
Q4 2025 - Strategisk omställning och portföljförvärv ledde till minskat substansvärde och negativt resultat.COLLAX
Q3 2025 - Strategic pivot to unlisted investments, with NAV per share dropping and major portfolio acquisition.COLLAX
Q2 2025 - NAV per share up 11% in Q3, with strong portfolio growth and improved profitability.COLLAX
Q3 2024 - Substansvärdet per stamaktie minskade 11% under H1 2024, men resultatet förbättrades.COLLAX
Q2 2024 - Substansvärdet minskade 6% och hela portföljen föreslås avyttras med extrautdelning.COLLAX
Q1 2025 - Stark vändning till positivt resultat och höjd utdelning trots lägre substansvärde.COLLAX
Q4 2024